IL17A and breast cancer: A role for IL-17 in promoting breast cancer progression and metastasis has been described, which is associated with a worse prognosis (Du et al., 2012; Chen et al., 2013; Jin and Dong, 2013, p. 1; Coffelt et al., 2015).